Key result
Lianqiaobaidu powder alleviates cardiac dysfunction in CVB3-infected mice by suppressing viral replication, inflammation, and apoptosis.
Lianqiaobaidu powder and its active constituents demonstrate complementary mechanisms in alleviating viral myocarditis in preclinical models.
Answers are grounded in this paper and cite their sources.
No current clinical role in viral myocarditis; extends preclinical evidence for complementary multi-target mechanisms via its key constituents.
• Lianqiaobaidu powder alleviates cardiac dysfunction and injury in CVB3-infected mice. • Nodakenin, Isosakuranin, and Epicatechin gallate are key LQBDP anti-VMC constituents. • Nodakenin inhibits CVB3 replication in cardiac fibroblasts via the MEK pathway. • Isosakuranin reduces inflammation in CVB3-infected macrophages via the RAGE pathway. • Epicatechin gallate blocks CVB3-induced cardiomyocyte apoptosis via the TNFR pathway.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2026) studied this question. Lianqiaobaidu powder alleviates cardiac dysfunction in CVB3-infected mice by targeting viral replication, inflammation, and apoptosis via key constituents Nodakenin, Isosakuranin, and Epicatechin gall.
Synapse has enriched 10 related papers. Consider them for comparative context: